JBHT
NASDAQ · Road & Rail
Hunt (Jb) Transprt Svcs Inc
$237.41
+1.24 (+0.53%)
JBHT News24 articles
Vantora Secures $100M to Fund Customer-Owned AI Ventures
Vantora, the venture builder formerly known as UP.Labs, raised over $100M from Silversmith Capital Partners to scale its model of customer-owned AI ventures.
Trucker Strike Rumors Debunked as Diesel Prices Hit Record $6.285
No verified nationwide trucker strike is scheduled for Oct. 1, despite social media claims. Diesel prices hit a record $6.285, but J.B. Hunt (JBHT) shares showed no panic.
Diesel at Record High Sends J.B. Hunt Shares Down Nearly 13%
J.B. Hunt shares tumbled nearly 13% after record diesel prices hit $6.40, adding at least $10M in fuel costs. The stock rebounded slightly but remains down.
Dow Tumbles 631 Points as Warsh Signals More Hikes Ahead
The Dow fell 631 points after Fed Chair Warsh hinted at another rate hike in 2026. Banks and transports led losses, while tech stocks cushioned the Nasdaq.
J.B. Hunt Surges 6.6% as Intermodal Drives 89% of Income Growth
J.B. Hunt shares rose 6.6% as intermodal contributed 89% of operating-income growth, with management eyeing pricing as the next margin lever.
J.B. Hunt Intermodal Drives 89% of Profit Surge in Q2
J.B. Hunt's intermodal unit accounted for $55.1 million of its $62.2 million operating profit increase in Q2, driving shares up 6.9% after hours.
Tech Rout Deepens as AI Stocks Tumble, Oil Surge Stirs Inflation Jitters
US stocks slumped Wednesday as AI stocks slid on dilution fears from Super Micro Computer's $7 billion financing plan, while surging oil prices stoked inflation worries, dragging the S&P 500 down 1.56%.
Dow Slips as CPI Meets Forecasts, Iran Tensions and AI Selloff Weigh
The Dow dropped 0.55% as May CPI matched forecasts at 4.2% YoY, but energy-driven inflation and geopolitical jitters kept markets on edge, with AI stocks like SMCI falling sharply.
Huntington Cuts 2027 EPS Outlook as Deposit Costs Bite
Huntington Bancshares reduced its 2027 adjusted EPS forecast to $1.75-$1.83, citing deposit pricing and loan growth constraints. Shares dropped 5.55%.
Take-Two Escalates GTA VI Leak Hunt with Second Discord Subpoena
Take-Two Interactive obtained a second federal subpoena for Discord in its GTA VI leak investigation. The move adds legal pressure but doesn't confirm a leaker's identity.
Huntington's Valuation Gap Widens as Q4 Synergy Deadline Looms
Huntington Bancshares (HBAN) closed at $17.60, up 0.2%, but trades at a 14% tangible-book discount to peers. Q4 synergy execution is now the key catalyst.
Huntington Bancshares Falls on Weak Interest Income, Merger Doubts
Huntington Bancshares shares fell 1.1% after net interest income missed expectations, leading to a Bank of America downgrade and raising questions about merger benefits.
Huntington Bancshares Declines 4.9% as Rising Deposit Costs Pressure Margins
Huntington Bancshares (NASDAQ:HBAN) shares dropped 4.9% this week as rising deposit costs and a declining net interest margin overshadowed solid fee income growth.
Huntington Bancshares Slips 5% on Deposit Cost Pressure Despite Strong Organic Growth
Huntington Bancshares shares dropped 5.1% on Thursday as rising deposit costs and a declining net interest margin overshadowed strong organic deposit growth.
Huntington Bancshares Q2 Preview: Deal-Driven Growth Meets EPS Expectations
Huntington Bancshares (HBAN) closes up 0.6% ahead of Q2 earnings, with analysts eyeing deal-driven EPS growth amid integration costs and margin pressures.
Bloom Energy Shares Slide on Hunterbrook Short Report Over China Scandium Supply
Bloom Energy shares dropped 7.6% after Hunterbrook released a short report alleging China-linked scandium supply risks could delay AI data center expansion.
UniQure Holds Gains as FDA Signals Path for Huntington's Gene Therapy Filing
UniQure shares jumped 78.4% after the FDA said Phase I/II data could support an accelerated-approval filing for its Huntington's disease gene therapy AMT-130. A BLA is planned for Q3 2026.
FDA Greenlights uniQure's Accelerated Approval Path for Huntington's Gene Therapy
uniQure shares surged 78% premarket after the FDA agreed to accept three-year Phase I/II data as the basis for an accelerated approval filing for AMT-130 in Huntington's disease, reviving the near-term U.S. path for the potential first disease-modifying treatment.
Huntsman Shares Plummet 18% After Olin All-Stock Merger Reveals Valuation Gap
Huntsman shares dropped 18% after Olin's all-stock merger deal valued the company below its last close, with the fixed exchange ratio linking its worth to Olin's declining stock price.
BofA CEO: Consumers Shift to Bargain Hunting Amid Inflation Squeeze
Bank of America card spending grew 5.1% YoY in May, fastest in nearly four years, but CEO Brian Moynihan warns consumers are trading down on purchases like pet food as inflation outpaces wage growth.
Huntington Bancshares Surges on Heavy Volume, Regional Banking Outlook Brightens
Huntington Bancshares jumped 1.49% on double-average volume, outperforming regional peers. Q1 net income hit $523M, adjusted EPS 37ยข, and Cadence Bank integration wraps in Q2. Management to present at Morgan Stanley June 9.
Huntington Bancshares Reaffirms 2026 Outlook Amid Stock Consolidation
Huntington Bancshares shares stabilized around $15.50 as management confirmed its 2026 financial guidance and projected $550 million in stock buybacks for that year, while anticipating significant cost savings from recent acquisitions.
Huntington Bancshares Shares Rebound on 2027 EPS Outlook and Merger Synergy Details
Huntington Bancshares stock rose 0.5% Wednesday, recovering from a prior sell-off, as investors assessed its 2027 EPS target of $1.90-$1.93 and $435M in projected annual cost synergies from recent acquisitions.
Huntington Bank Appoints Former BNY Risk Chief as CRO Amid Regulatory Shift
Huntington Bank has named Senthil Kumar, previously the top risk officer at BNY, as its new chief risk officer. The move follows the bank's entry into a stricter regulatory category after its merger with Cadence Bank pushed assets to $279 billion.